Please assess the completion status of the following clinical trial:

Trial Title: OxyPrem Validation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Substudy 1 (healthy adult volunteers)~Inclusion Criteria:~* Healthy adult~* Signed informed consent~Exclusion Criteria:~* Dense black hair at the location of measurement~* Neurological diseases.~Substudy 2 (preterm infants)~Inclusion Criteria:~* Pre-term neonates (gestational age at birth less than 37 weeks)~* Signed informed consent by at least one parent~Exclusion Criteria:~* Clinically instability~* Malformations

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- precision and accuracy study (Type: EXPERIMENTAL): precision and accuracy of Oxyprem are studied

Based on this trial design, predict the completion outcome and termination type (if applicable).